- Patent Title: Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof
-
Application No.: US17110004Application Date: 2020-12-02
-
Publication No.: US11292848B2Publication Date: 2022-04-05
- Inventor: Jeffry D. Watkins , Cindy T. Dickerson , Rafael Rojas , Matthew Reissman , Patricia McNeeley , Janine Bilsborough , Bradley Henkle , Stephan R. Targan
- Applicant: PROMETHEUS BIOSCIENCES, INC. , CEDARS-SINAI MEDICAL CENTER
- Applicant Address: US CA San Diego; US CA Los Angeles
- Assignee: PROMETHEUS BIOSCIENCES, INC.,CEDARS-SINAI MEDICAL CENTER
- Current Assignee: PROMETHEUS BIOSCIENCES, INC.,CEDARS-SINAI MEDICAL CENTER
- Current Assignee Address: US CA San Diego; US CA Los Angeles
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07K16/24
- IPC: C07K16/24 ; C07K16/28 ; A61P1/04 ; C07K14/52 ; C07K14/525 ; A61K39/395
Abstract:
Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
Public/Granted literature
- US20210122828A1 HUMANIZED ANTIBODIES TO TNF-LIKE LIGAND 1A (TL1A) AND USES THEREOF Public/Granted day:2021-04-29
Information query
